Intl Fcstone »

Adaptimmune Therapeutics shares owned by Intl Fcstone

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Intl Fcstone from 13F filings

Historical chart of Intl Fcstone investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Intl Fcstone consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Intl Fcstone

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0k 15k 0.13

More positions owned by Intl Fcstone

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Val Etf (IWD)
Schwab Strategic Tr Fundamental Intl (FNDF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Victory Portfolios Ii Shares Free Cash (VFLO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr S&p 500 Grwt Etf (IVW)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)

View all positions for Intl Fcstone

Top funds holding Adaptimmune Therapeutics

Long Focus Capital Management
UBS Group
Morgan Stanley
Renaissance Technologies
Jane Street
Acadian Asset Management
Empirical Finance
National Asset Management
Rathbones Brothers
FMR
Susquehanna International
Citadel Advisors
Lumbard Investment Counseling
Lakeridge Wealth Management
XTX Topco

View all funds holding Adaptimmune Therapeutics